BCL2L1 Antikörper

Produktnummer ABIN187417

Dieser Maus Monoklonal Antikörper detektiert spezifisch BCL2L1 in WB, IF, IHC (p), IHC (fro) und EIA. Es zeigt Reaktivität gegenüber Proben von Human, Maus, Ratte und Schwein.

Kurzübersicht für BCL2L1 Antikörper (ABIN187417)

Target: BCL2L1 (BCL2-Like 1 (BCL2L1))

Reaktivität: Human, Maus, Ratte, Schwein

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser BCL2L1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Enzyme Immunoassay (EIA)

Klon: 2H12

Produktdetails anti-BCL2L1 Antikörper

Spezifität: Reacts specifically with the Bcl-xL protein. Species Reactivity: Human, mouse and rat. Others not tested.

Immunogen: Synthetic peptide corresponding to aa 3-14 of the human Bcl-xL protein.

Isotyp: IgG2a

Anwendungsinformationen

Applikationshinweise: Western blot: Use at 1-5 µg/mL. The optimal dilution for a specific application should be determined by the researcher.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: 100 µg purified IgG at approx. 1 mg/mL. Purified from ascites fluid.

Lagerung: -20 °C

Details zu BCL2L1

Target: BCL2L1 (BCL2-Like 1 (BCL2L1))

Andere Bezeichnung: Bcl-2-like 1

Hintergrund: Bcl-xL is structurally related to the Bcl-2 gene and is a member of the Bcl-2 family of oncoproteins. Overexpression of Bcl-xL to other Bcl-2 members is believed to promote cell survival, its ratio to other Bcl-2 family members is believed to modulate the apoptotic process.

Pathways: Apoptose, Negative Regulation of intrinsic apoptotic Signaling